Date:1/30/2009

31, 31, 31, 2008 2007 2008 2007 Revenue: CAG (1) $196,523 $197,240 $834,056 $750,449 Water 17,182 17,294 74,469 66,235 PAS 20,310 22,214 80,762 75,085 Other (1) 9,278 8,221 34,743 30,786 Total $243,293 $244,969 $1,024,030 $922,555 Gross Profit: CAG (1) $90,359 $93,720 $412,199 $362,162 Water 11,479 10,696 47,052 41,656 PAS 14,307 14,051 55,005 46,728 Other (1) 4,289 3,643 15,131 12,455 Unallocated 87 134 379 521 Total $120,521 $122,244 $529,766 $463,522 Income from Operations: CAG (1) $24,210 $25,878 $129,620 $100,285 Water 7,893 6,837 31,330 26,847 PAS 6,936 5,170 21,760 15,456 Other (1) 919 604 1,555 1,003 Unallocated (4,109) (1,747) (11,809) (7,408) Total $35,849 $36,742 $172,456 $136,183 Gross Profit (as a percentage of revenue): CAG 46.0% 47.5% 49.4% 48.3% Water 66.8% 61.8% 63.2% 62.9% PAS 70.4% 63.3% 68.1% 62.2% Other 46.2% 44.3% 43.6% 40.5% Income from Operations (as a percentage of revenue): CAG 12.3% 13.1% 15.5% 13.4% Water
'/>"/>

SOURCE IDEXX Laboratories, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Related medicine news :

1. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Names William Brown Corporate Vice President
3. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. IDEXX Laboratories Announces Increase in Share Repurchase Program
6. IDEXX Laboratories Announces Fourth Quarter Results
7. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
11. Metametrix Announces Acquisition of Accu-Chem Laboratories